Orthofix Medical Inc. Income (Loss) from Continuing Operations, Per Diluted Share
Orthofix Medical Inc. (OFIX) reported Income (Loss) from Continuing Operations, Per Diluted Share of $0.60 per share for the 3-month period ending 2019-12-31, per its 10-K filed 2020-02-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2020-02-24
- Orthofix Medical Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2019-12-31 was $0.60, a 30.43% increase year-over-year.
- Orthofix Medical Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2019-09-30 was -$2.14.
- Orthofix Medical Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2019-06-30 was -$0.03, a 160.00% decline year-over-year.
- Orthofix Medical Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2019-03-31 was $0.05, a 81.48% decline year-over-year.
- Orthofix Medical Inc. income (loss) from continuing operations, per diluted share for fiscal 2019 was -$1.51, a 309.72% decline from fiscal 2018.
- Orthofix Medical Inc. income (loss) from continuing operations, per diluted share for fiscal 2018 was $0.72, a 84.62% increase from fiscal 2017.
- Orthofix Medical Inc. income (loss) from continuing operations, per diluted share for fiscal 2017 was $0.39, a 105.26% increase from fiscal 2016.
- Orthofix Medical Inc. income (loss) from continuing operations, per diluted share for fiscal 2016 was $0.19.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 12 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | $0.60 10-K · filed 2020-02-24 | -$1.51 10-K · filed 2020-02-24 | ||||||
| 2019-09-30 | -$2.14 10-K · filed 2020-02-24 | |||||||
| 2019-06-30 | -$0.03 10-K · filed 2020-02-24 | |||||||
| 2019-03-31 | $0.05 10-K · filed 2020-02-24 | |||||||
| 2018-12-31 | $0.46 10-K · filed 2020-02-24 | $0.72 10-K · filed 2020-02-24 | ||||||
| 2018-09-30 | -$0.07 10-K · filed 2020-02-24 | $0.26 10-Q · filed 2018-10-29 | ||||||
| 2018-06-30 | $0.05 10-K · filed 2020-02-24 | $0.32 10-Q · filed 2018-08-06 | ||||||
| 2018-03-31 | $0.27 10-K · filed 2020-02-24 | |||||||
| 2017-12-31 | $0.08 10-K · filed 2019-02-25 | $0.39 10-K · filed 2020-02-24 | ||||||
| 2017-09-30 | $0.18 10-K · filed 2019-02-25 | $0.31 10-Q · filed 2018-10-29 | ||||||
| 2017-06-30 | $0.26 10-K · filed 2019-02-25 | $0.13 10-Q · filed 2018-08-06 | ||||||
| 2017-03-31 | -$0.13 10-K · filed 2019-02-25 | |||||||
| 2016-12-31 | -$0.29 10-K · filed 2018-02-26 | $0.19 10-K · filed 2019-02-25 | ||||||
| 2016-09-30 | $0.56 10-K · filed 2018-02-26 | $0.46 10-Q · filed 2017-10-30 | ||||||
| 2016-06-30 | -$0.35 10-K · filed 2018-02-26 | -$0.10 10-Q · filed 2017-08-07 | -$0.09 10-Q · filed 2016-08-01 | |||||
| 2016-03-31 | $0.24 10-K · filed 2018-02-26 | $0.25 10-Q · filed 2016-04-28 | ||||||
| 2015-12-31 | $0.11 10-K · filed 2017-02-27 | -$0.12 10-K · filed 2018-02-26 | ||||||
| 2015-09-30 | -$0.04 10-K · filed 2017-02-27 | -$0.24 10-Q · filed 2016-10-31 | ||||||
| 2015-06-30 | $0.21 10-K · filed 2017-02-27 | -$0.20 10-Q · filed 2016-08-01 | ||||||
| 2015-03-31 | -$0.41 10-K · filed 2017-02-27 | |||||||
| 2014-12-31 | -$0.27 10-K · filed 2016-02-29 | -$0.20 10-K · filed 2017-02-27 | ||||||
| 2014-09-30 | $0.00 10-K · filed 2016-02-29 | $0.07 10-Q · filed 2015-11-03 | ||||||
| 2014-06-30 | $0.18 10-K · filed 2016-02-29 | $0.07 10-Q · filed 2015-08-04 | -$0.07 10-Q · filed 2015-03-31 | |||||
| 2014-03-31 | -$0.11 10-K · filed 2016-02-29 | -$0.01 10-Q · filed 2014-05-08 | ||||||
| 2013-12-31 | -$0.53 10-K · filed 2015-04-29 | -$0.47 10-K · filed 2014-03-31 | -$0.97 10-K · filed 2015-04-29 | -$0.80 10-K · filed 2014-03-31 | ||||
| 2013-09-30 | -$0.91 10-K · filed 2015-04-29 | -$1.00 10-Q · filed 2014-03-25 | -$0.45 10-Q · filed 2015-03-31 | -$0.34 10-Q · filed 2014-03-25 | ||||
| 2013-06-30 | $0.10 10-K · filed 2015-04-29 | $0.21 10-Q · filed 2014-03-24 | $0.41 10-Q · filed 2015-03-31 | $0.60 10-Q · filed 2014-03-24 | ||||
| 2013-03-31 | $0.30 10-K · filed 2015-04-29 | $0.25 10-Q · filed 2013-05-09 | ||||||
| 2012-12-31 | $0.89 10-K/A · filed 2015-03-31 | $0.74 10-K · filed 2013-03-01 | $2.33 10-K · filed 2015-04-29 | $2.78 10-K · filed 2013-03-01 | ||||
| 2012-09-30 | $0.48 10-K/A · filed 2015-03-31 | $0.67 10-Q · filed 2012-11-02 | $1.51 10-Q · filed 2014-03-25 | $2.04 10-Q · filed 2012-11-02 | ||||
| 2012-06-30 | $0.59 10-K/A · filed 2015-03-31 | $0.73 10-Q · filed 2012-07-30 | $0.96 10-Q · filed 2014-03-24 | $1.37 10-Q · filed 2012-07-30 | ||||
| 2012-03-31 | $0.36 10-K/A · filed 2015-03-31 | $0.64 10-K · filed 2013-03-01 | ||||||
| 2011-12-31 | $0.41 10-K/A · filed 2014-03-24 | $0.62 10-K · filed 2013-03-01 | -$0.87 10-K/A · filed 2015-03-31 | -$0.10 10-K · filed 2013-03-01 | ||||
| 2011-09-30 | $0.60 10-K/A · filed 2014-03-24 | $0.69 10-Q · filed 2012-11-02 | -$0.73 10-Q · filed 2012-11-02 | |||||
| 2011-06-30 | $0.35 10-K/A · filed 2014-03-24 | $0.57 10-Q · filed 2012-07-30 | -$1.45 10-Q · filed 2012-07-30 | |||||
| 2011-03-31 | -$2.33 10-K/A · filed 2014-03-24 | -$2.05 10-K · filed 2013-03-01 | ||||||
| 2010-12-31 | $1.73 10-K/A · filed 2014-03-24 | $1.55 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |